CURRENT MOLECULAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2024-12-09 ms6000000372692146 来自湖北省

审稿速度:2.0 | 投稿命中率:50.0
经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀

76 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2023-06-20 ms2000000713462597 来自江西省

审稿速度:12.0 | 投稿命中率:25.0
经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究
sci分在不断往下走，真心不建议试投。

152 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2022-06-13 ms9000000393798485

审稿速度:12.0 | 投稿命中率:50.0
经验分享：迟迟不见状态改变啊

114 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

如何判断两种药物之间是协同作用还是相加作用？

117 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

如果文章发表了未提供ORCIDID如何添加？

114 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2019-08-22 才开始

请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表::
已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表:
已经投稿1年多了，还是没有动静，这是怎么回事啊

lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊

222 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2018-04-01 lixindentist

已经投稿1年多了，还是没有动静，这是怎么回事啊

358 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2017-07-18 13801938855

跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜

359 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2241591, encodeId=7f2222415918a, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：怎么大家都这个杂志运气都不好呀，我投了两个月多一点就返修了，给了十几条意见，给的意见还挺中肯的，返修后不到两周就接收了，感觉还挺快的呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89a39173582, createdName=ms6000000372692146, createdTime=Mon Dec 09 23:21:26 CST 2024, time=2024-12-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2143876, encodeId=bbe321438e667, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：7个多月后给出拒稿，基因家族在胃癌中的生信研究 sci分在不断往下走，真心不建议试投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Tue Jun 20 13:36:38 CST 2023, time=2023-06-20, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=1226110, encodeId=017f122611088, content=审稿速度:12.0 | 投稿命中率:50.0 经验分享：迟迟不见状态改变啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83178200737, createdName=ms9000000393798485, createdTime=Mon Jun 13 08:59:36 CST 2022, time=2022-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087225, encodeId=2d2a108e225fe, content=如何判断两种药物之间是协同作用还是相加作用？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087226, encodeId=5f43108e226b2, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575205, encodeId=bab65e520509, content=请问最后多久给消息了呀？是好消息还是坏消息？lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊lixindentist 2018-04-01 15:13:00 发表: 已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=lixindentist 2018-04-01 发表:: 已经投稿1年多了，还是没有动静，这是怎么回事啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=78212477466, createdName=才开始, createdTime=Thu Aug 22 00:00:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554412, encodeId=cc305544124b, content=已经投稿1年多了，还是没有动静，这是怎么回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=358, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=afc01712357, createdName=lixindentist, createdTime=Sun Apr 01 15:13:00 CST 2018, time=2018-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539888, encodeId=a2bf5398883a, content=跌跌不休，再往下，会不会破2。一年就跌下不少，哪怕0.1分，也应该值得珍惜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=359, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=13801938855, createdTime=Tue Jul 18 18:36:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537766, encodeId=5a1a53e766e4, content=一审到接收，1年半, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=425, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e49d1622204, createdName=xiaxianyue1912, createdTime=Wed Jun 14 07:54:00 CST 2017, time=2017-06-14, status=1, ipAttribution=)]

2017-06-14 xiaxianyue1912

一审到接收，1年半

425 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务